JPRN-UMIN000035716尚未招募未知
A prospective multicenter trial of clot pathology in acute stroke - A prospective multicenter trial of clot pathology in acute stroke
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Other than key inclusion criteria
研究者
相似试验
尚未招募
不适用
A multicenter prospective clinical study for the treatment of spleen and kidney insufficiency metrorrhagia and metrostaxis with Lingnan Hemostatic Prescription Erren DecoctioITMCTR1900002640The First Affiliated Hospital of Guangzhou University of Chinese Medicine
进行中（未招募）
不适用
A prospective, randomised, multicenter clinical trial investigating the reduction of Calcineurin inhibitor toxicity by means of steroid free long-term immune suppression with Ciclosporin A and Mycophenolat mofetil in children and adolescents after kidney transplantation - Recaltox-1EUCTR2007-001166-33-DEniversitaetsklinikum Erlangen-Nuernberg
已完成
不适用
se of biosynthetic material (MegaDerm) as reinforcing buttress material of anastomotic sites after gastric resectioNeoplasmsKCT0002715Korea University Anam Hospital100
尚未招募
Unknown
A prospective clinical multicenter study to evaluate the safety, performance and subject satisfaction when using hyaluronic acid fillers from the Mona Lisa product range by GENOSS to build facial volume and contour the face and their comparison to products from the manufacturers Across, Allergan, Galderma and Vivacyhypovolaemia, hypotrophy, atrophy, loss of contour, excess skinDRKS00033799GENOSS700
进行中（未招募）
不适用
AN OPEN, RANDOMISED, MULTICENTRE, CLINICAL STUDY TO COMPARE THE SAFETY AND EFFICACY OF TACROLIMUS AND MINIMAL STEROIDS IN COMBINATION WITH EITHER A MONOCLONAL ANTI-IL2R ANTIBODY (DACLIZUMAB) OR MYCOPHENOLATE MOFETIL IN LIVER ALLOGRAFT TRANSPLANTATION - Marsilea (Mycophenolate mofetil or Antibodies with Reduced Steroids in Liver transplantation)Patients with hepatic disease who will undergo primary orthotopic liver or split liver allograft transplantation.MedDRA version: 7.0Level: LLTClassification code 10019650EUCTR2004-001617-34-GBAstellas Pharma Europe Ltd600